Abstract:Background COVID-19 is a new and highly contagious respiratory disease that has caused global spread, high case fatality rate in severe patients, and a huge medical burden due to invasive mechanical ventilation. The current diagnosis and treatment guidelines are still need to be improved, and more excellent clinical experience is needed to provide reference. Methods We analyzed and summarized clinical data of 97 confirmed COVID-19 adult patients (including 26 severe cases) admitted to the Fifth Affiliated Hospital of Sun Yat-sen University from January 17, 2020 to March 10, 2020, included laboratory examination results, imaging findings, treatment effect, prognosis, etc, in order to put forward prediction index of severe COVID-19 patients, principles of early intervention and methylprednisolone usages in COVID-19 patients. Results 1. Hypoxemia, hyperlactic acid, hypoproteinemia, and hypokalemia were prevalent in COVID-19 patients. The significant low lymphocyte count, hypoproteinemia, hypokalemia, the persistent or worsen high CRP, high D-dimer, and high BNP, and the occurrence of hemoptysis and novel coronavirus (SARS-CoV-2) viremia were important indicators for early diagnosis and prediction of severe disease progression. 2. Characteristic images of lung CT had a clear change in COVID-19, Ground-glass opacity (GGO) and high-density linear combinations may indicate different pathological changes. Rapid lobular progression of GGO suggests the possibility of severe disease. 3. Basic principles of early intervention treatment of COVID-19: on the premise of no effective antiviral drugs, treatment is based on supportive and symptomatic therapy (albumin supplementation, supplement of potassium, supplement blood plasma, etc.) in order to maintain the stability of the intracellular environment and adequately reactivate body immunity to clean up SARS-CoV-2. 4. According to severity, oxygenation index, body weight, age, underlying diseases, appropriate amount methylprednisolone application on severe/critical COVID-19 patients on demand, improved blood oxygen and reduced the utilization rate of invasive mechanical ventilation, case fatality rate and medical burden significantly. The most common indications for invasive mechanical ventilation should be strictly control in critical COVID-19 patients. Conclusions 1. Accurate and timely identification of clinical features in severe risks, and early and appropriate intervention can block disease progression. 2. Appropriate dose of methylprednisolone can effectively avoid invasive mechanical ventilation and reduce case fatality rate in critical COVID-19 patients. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial This study is a retrospective observational study, so we do not need a trial ID ### Funding Statement NO funding ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The readers can access the data supporting the conclusions of the study in the manuscript and updated manuscript if the data has been updated

Case Report: Opportunities for Treatment of Severe COVID-19 Patients—Lessons From a Death Case

Clinical Interventions for Severe and Critical COVID-19: What Are the Options

Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China

Key to successful treatment of COVID 19: accurate identification of severe risks and early intervention of disease progression

A young severe COVID-19 case complicated with repeat pneumothorax

Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients

[Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients].

Case–control study on risk factors for in-hospital mortality in patients with severe COVID-19

Risk factors associated with fatal outcomes of novel coronavirus infection pneumonia (COVID-19): A systematic review and meta-analysis

Early Antiviral Treatment Contributes to Alleviate the Severity and Improve the Prognosis of Patients with Novel Coronavirus Disease (COVID-19)

Clinical Characteristics and Treatment of Critically Ill Patients with COVID-19 in Hebei.

Risk Factors for Fatal Outcome in Patients with Severe COVID-19: an Analysis of 107 Cases in Wuhan

Epidemiological and Clinical Characteristics of 47 Corona Virus Disease 2019 Non-Survivors in Huoshenshan Hospital

Critical care for severe coronavirus disease 2019: a population-based study from a province with low case-fatality rate in China

Early and Critical Care in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19

The characteristics and outcomes of 681 severe cases with COVID-19 in China

Clinical Course and Features of Critical Patients with COVID-19: a Single- Center, Retrospective Study from Wuhan Huoshenshan Hospital

COVID-19 with pleural effusion as the initial symptom: a case study analysis

Disease Progression Patterns And Risk Factors Associated With Mortality In Deceased Patients With Covid-19 In Hubei Province, China

Severe covid-19 pneumonia: pathogenesis and clinical management